Heleen Vroman

4PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 19, 2020
PD-L1+ lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients.

A Raniszewska, H Vroman, D Dumoulin

|Jul 22, 2020
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model.

Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman

|Apr 03, 2020
T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma.

Heleen Vroman, Giulia Balzaretti, Robert A Belderbos

|Sep 02, 2018
House dust mite-driven neutrophilic airway inflammation in mice with TNFAIP3-deficient myeloid cells is IL-17-independent.

Heleen Vroman, Tridib Das, Ingrid M Bergen

Pageof 1